MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...
Asian News International on MSN5d
Antibody-based therapy several notches closer to treat lethal mucormycosis: StudyMucormycosis, a fungus infection caused by Mucorales, has a high mortality rates in those with weakened immune systems and ...
The Japanese Ministry of Health, Labour and Welfare on Thursday approved Genmab A/S’ (NASDAQ:GMAB) Tivdak (tisotumab vedotin) ...
Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.
ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...
Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.
New active ingredients such as antibodies are usually tested individually in laboratory animals. Researchers have now developed a technology that can be used to test around 25 antibodies ...
The damage to blood vessels is concerning because it's how antifungal drug therapy is delivered to the infection site. "Our humanized monoclonal antibody allows antifungal drug therapy to reach to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback